Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about alzheimer's

Recent news which mentions alzheimer's

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
Tickers NEWS SAVA
Tags Health Care alzheimer's Benzinga
From Benzinga
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
Tickers ACOG JNJ NEWS
Tags Briefs General Market News
From Benzinga
Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
Tickers IGC NEWS
Tags Health Care premium Benzinga
From Benzinga
Eli Lilly Says New Data Can Potentially Provide Path To Improved Donanemab Profile By Lower Risk Of Imaging Abnormalities In Patients With Early Alzheimer's
Tickers LLY NEWS
Tags News LLY Top Stories
From Benzinga
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
Tickers ABBV SHL
Tags Expert Ideas Top Stories ABBV
From Benzinga
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
Tickers NEWS NXL NXLIW
Tags NXLIW Biotech NXL
From Benzinga
EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study
Tickers NEWS NXL NXLIW
Tags Stories That Matter Benzinga Market/Moving Exclusives
From Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
Tickers BIIB NEWS SAGE
Tags why it's moving Biotech alzheimer's
From Benzinga
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks
Tickers ATHA NEWS
Tags why it's moving Biotech ATHA
From Benzinga
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
Tickers NEWS SAVA
Tags Stories That Matter Trading Ideas Benzinga
From Benzinga
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
Tickers NEWS SAVA
Tags Health Care Hoau/Yan Wang FDA
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Tickers ACIU BIIB ESAIY ESALY
Tags LLY Small Cap BIIB
From Benzinga
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
Tickers ALZN BIIB LLY SAVA
Tags Biotech SAVA Alzheimer's disease
From Benzinga
Tesla, Amazon, Microsoft, Cassava Sciences, Intuitive Surgical: Why These 5 Stocks Are Drawing Investors' Attention Today
Tickers AMZN ISRG MSFT SAVA
Tags AMZN Markets Benzinga
From Benzinga
Psychedelics For Alzheimer's And Stress-Induced Disorders Under Study At Columbia University
Tickers SILO
Tags Psilocybin News Cannabis
From Benzinga
Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
Tickers AAPL BIIB QQQ SPY
Tags AAPL News BIIB
From Benzinga
Why Biogen Stock Is Up 40% Today
Tickers BIIB ESALY
Tags ESALY why it's moving Biotech
From Benzinga
Brain Awareness Month: Bittersweet glimpse into early-dementia via video by Entertainer Carissa Biele
Tickers VNUE
Tags Marketing #countrymusic vnue
From PRUnderground
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
Tickers AXSM JNJ PLUG RBLX
Tags News Small Cap Crowdsourcing
From Benzinga
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
Tickers IGC THC
Tags Biotech Penny Stocks THC
From Benzinga
The Walk To End Alzheimer’s Partnership
Tags VHS to DVD Alzheimer's Digitizing Memories
From PRUnderground
Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions
Tickers ASIA TC
Tags Startups Neuroglee Therapeutics Southeast Asia
From TechCrunch
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
Tickers BIIB ESALY
Tags Market News Aduhelm General
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.